Katharine Derrey is the founder of the Hopewell Foundation for Regenerative Medicine, a nonprofit dedicated to accelerating the development of regenerative technologies for nasal reconstruction. Her work focuses on bridging the gap between laboratory innovation and patient care by supporting advancements in tissue engineering and 3D bioprinting. Katharine’s advocacy is deeply personal. After experiencing a life-altering surgical outcome that required multiple reconstructive procedures, she became committed to advancing safer, more effective solutions for patients. She now works to unite researchers, clinicians, and patient communities to help bring next-generation regenerative therapies into clinical reality.

Derek Martinez is a Biology lecturer at the University of New Mexico–Los Alamos Campus. He earned an M.S. in Biomedical Engineering from the University of New Mexico School of Engineering in 2020. He has taught several undergraduate courses, including Human Body, Anatomy and Physiology, Biology for Health Sciences, and Organic Chemistry. His research interests include cancer biology, metabolism, gene therapy, and clinical applications of induced pluripotent stem cells. He was recently recognized as a ROSE Scholar for his work on mesoporous silica nanoparticles for drug delivery. He also develops evidence-based, inclusive, interactive learning software (digital activities) to support improved learning outcomes in Biology for Health Sciences, and he is interested in creating similar resources for Organisms to Ecosystems, Anatomy and Physiology, and Microbiology for Health Sciences.

Dr. Omid Liaghati, MD, CCFP, CAPM is a licensed Canadian family physician specializing in chronic pain management. He combines medication and interventional techniques in his practice, including nerve blocks, chemical nerve ablation, PRP therapy, stem cell therapy, and phototherapy to provide comprehensive care for patients with persistent pain.

Dr. Victor Manuel Flores Rodriguez has a strong background in research and development, specializing in regenerative medicine through the use of biotechnological products such as mesenchymal stem cells, exosomes, secretomes, fibroblasts, and natural killer cell therapy for cancer patients, combined with peptide therapy. He received training in CAR T Cell therapy at the Institute of Biomedicine of Seville (IBIS) and is an active member of both the Spanish Society for Gene and Cell Therapy and the International Society for Stem Cell Research (ISSCR). Dr. Flores Rodriguez has served as a lecturer in cell therapy diploma programs for the medical community in Latin America and Europe and has extensive experience as a speaker at national and international conferences on topics related to cell therapy and its legislation. He currently collaborates with the Alternative Medicine by Bars Regenerative Center and serves as CEO of a brand dedicated to disseminating advances in regenerative medicine.

Dr. Kaijing Yan, Ph.D. is the Director of the Tasly Institute of Life Rejuvenation in Tianjin, China, and Chairman of the Tasly Bio-Medicinal Industry Group. An accomplished scientist and entrepreneur, Dr. Yan holds degrees in computer science, finance, and traditional Chinese medicine, along with postdoctoral training in stem cells and regenerative medicine. He leads pioneering research that integrates AI, single-cell omics, and clinical translation of regenerative therapies, contributing to U.S. FDA–approved stem cell products and advancing the global understanding and clinical application of mesenchymal stromal cells (MSCs).

Dr. Schaefer is a senior researcher and lecturer at the University and University Hospital in Basel, Switzerland. A biochemist by training, he specializes in the PI3K/AKT signaling path way and the molecular-functional regulation of the stem cell factor SOX2.With more than 20 years of professional experience in academia and industry, Dr. Schaefer is a standing member of the German Society for Hematology and Medical Oncology (DGHO), the American Association of Cancer Research (AACR), the American Chemical Society (ACS), and the Biochemical Society, London. The work presented was funded by Swiss Cancer Research (KFS-4852082019R) and the Swiss National Science Foundation (SNSF-10.004.128). Dr. Schaefer declares no conflicts of interest. Additional information is available at ORCID 0000-0003-4867-8374.

Dr. Yan Xiaojun is the CTO of CytoNiche and the principal inventor of the 3D FloTrix™ technology. With over 10 years of experience in 3D cell culture and drug screening, she has published 22 SCI papers and filed 79 patents (62 in China, 17 internationally), with 57 patents granted and 3 software copyrights.

Ms. Brooke Morrisseau is the CEO of Cellovian Scientific and a regenerative medicine and biologics educator specializing in the translation of foundational cell physiology, biologic structure, and tissue engineering principles into responsible clinical education and implementation. Her work focuses on helping clinicians develop a signaling- and structure-based understanding of biologic systems to support informed, independent decision-making in clinical practice. She has served as a scientist at SUNY Oswego and Keuka College, where her work involved biologics and protein purification with emphasis on biologic structure and cell signaling mechanisms. Brooke has also served as an educator at the University of South Florida, teaching body composition and human metabolism, further grounding her work in applied physiology and translational science. Her entry into regenerative medicine was shaped by a personal experience that led to deeper study of cell science and the body's inherent repair processes. Today, her teaching emphasizes education-first frameworks, manufacturing transparency, and ethical knowledge transfer, underscoring that sustainable progress in regenerative medicine and biologics depends not only on scientific innovation, but on how well foundational physiology is understood and responsibly implemented in clinical settings.

Dr. Bradley Johnson practices in Interventional Chronic Pain in Ontario, Canada. His practice uses a combination of Phenol Chemical Ablation, Local Anesthetic, Neuromodulators, Platelet Rich Plasma, and Exosomes in order to treat chronic pain. Dr. Johnson is an Advanced Diplomate of the Canadian Academy of Pain Medicine, a member of the American Academy of Pain Medicine, and holds a Faculty position in the Department of Family Medicine at McMaster University in Hamilton, Ontario. Dr. Johnson has a keen interest in using different types of interventional procedures in order to help improve the function and quality of life for his patients.

Thomas J. Webster’s (H index: 137) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995; USA) and in biomedical engineering from RPI (Ph.D., 2000; USA). He has formed over a dozen companies who have numerous FDA approved medical products currently improving human health in over 45,000 patients. He is currently helping those companies and serves as a professor at Brown University, Saveetha University, HebeiUniversity of Technology, UFPI, University of the Basque Country, and others. Dr. Webster has numerous awards including: 2020, World Top 2% Scientist by Citations (PLOS); 2020, SCOPUS Highly Cited Research (Top 1% Materials Science and Mixed Fields); 2021, Clarivate Top 0.1% Most Influential Researchers (Pharmacology and Toxicology); 2022, Best Materials Science Scientist by Citations (Research.com); and is a fellow of over 8 societies.Prof. Webster is a former President of the U.S. Society for Biomaterials and has over 1,350 publications to his credit with over 55,000 citations. He was recently nominated for the Nobel Prize in Chemistry. Prof. Webster also recently formed a fund to support Nigerian student research opportunities in the U.S.

Dr. Karla Aidee Aguayo Cerón is a Professor and Researcher at the National Polytechnic Institute (Mexico). She received her M.D. from the Meritorious Autonomous University of Puebla and her M.Sc. from the National Polytechnic Institute. She also completed a research fellowship at the Laboratory of Molecular Signaling in the School of Medicine of the National Polytechnic Institute. In 2022, she began her postdoctoral work in the Genetic Research in Metabolic Diseases Laboratory, where she also served as an Assistant Professor. She actively participates in the Master’s and Ph.D. programs in Science at the School of Medicine of the National Polytechnic Institute. Her research focuses on developing in vitro models of inflammation to study the molecular pathways involved in metabolic diseases. In addition, she investigates the differentiation process of mesenchymal stem cells to better understand how changes in this process influence inflammation and their impact on other cells within the same microenvironment.

Dr. Rozina Badal Munir is an esteemed physician specializing in education in Diagnostic medical ultrasound and regenerative medicine. She received her MBBS from Khyber Medical College Pakistan andheld many board certifications in diagnostic medical sonography and regenerative medicine. With a longstanding position as an Ultrasound Specialist and Instructor at Kaiser Permanente West Los Angeles Medical Center, she has played a great role in promotion of diagnostic medical ultrasound education globally. As the Global Development Director of the American Board of Regenerative Medicine (ABRM), Dr. Munir has led international efforts to standardize the regenerative medicine education and certification across more than 30 countries and established 20 exam centers globally for ABRM written exams. She has also delivered hands-on workshops and symposia worldwide, with a focus on integrating point-of-care ultrasound in regenerative and emergency medicine. Dr. Munir has presented at major national and international conferences and contributed to medical journals in both regenerative medicine and diagnostic medical ultrasound. Her mission continues to mentor and train healthcare professionals globally.

Will be updated soon

Dr. Cynthia N. Brysch is an award-winning life sciences executive with a distinguished career spanning over two decades. She is globally certified in Quality Assurance (QA) and Regulatory Affairs (RA) and serves as a highly regarded principal consultant in the industry. Her expertise encompasses domestic and international compliance frameworks, including GxP and ICH standards. With over 10 years of leadership experience as an ISO 13485/9001 accrediting authority, ICH committee member, FDA lead assessor, and recognized Key Opinion Leader (KOL), Dr. Brysch has played a pivotal role in shaping global regulatory standards and challenging industry norms. She has directed more than 500 product development campaigns, including initiatives in rare diseases and advanced therapies such as cell and gene therapies. Her notable achievements include securing marketing authorizations for 18 of the top 20 oncology combination products and contributing to the approval of the first CRISPR-Cas9 therapeutic. As a trusted principal consultant, Dr. Brysch has led comprehensive programs across the full product lifecycle—from early-stage research and non-clinical studies to clinical development and manufacturing. Her client portfolio ranges from innovative startups to established pharmaceutical, medical device, and biopharmaceutical companies. Renowned for her strategic insight and operational leadership, Dr. Brysch develops risk-based, data-driven compliance strategies that align scientific innovation with regulatory success. Her work continues to drive efficiency, strengthen stakeholder confidence, and support the successful commercialization of breakthrough medical products worldwide.

Dr. Andisheh Dadashi is a computational biologist, statistician, mathematician, and assistant professor at the University of New Mexico–Valencia, USA. With dual Master’s degrees in Statistics and Mathematical Statistics, and a Ph.D. in Computer Science, Dr. Dadashi specializes in high-performance computing, metabolic modeling, and data-driven systems biology. Her interdisciplinary approach bridges computer science, statistics, and molecular biology. Her research presents the first stage-specific in silico model of human peri-implantation embryo metabolism, combining flux balance analysis (FBA) and network expansion algorithms to simulate complex metabolic processes during early development. This model has led to novel insights into the lactate-associated malate-aspartate shuttle (MAS) and metabolic regulation under varying oxygen and nutrient conditions, offering implications for regenerative medicine, stem cell research, and developmental biology. Dr. Dadashi has received international recognition for her contributions to computational biology and embryology, including Best Presentation Awards at ICBCB in Tokyo and invitations to serve as a session chair at global symposia. She is passionate about integrating mathematical modeling with experimental data to drive discoveries in embryonic development and biomedical innovation. In addition to her research, Dr. Dadashi is a dedicated educator and curriculum innovator, having taught a wide range of courses across computer science, data science, statistics, and mathematics. She is deeply committed to inclusive, interdisciplinary pedagogy, and was honored with the 2025 UNM Teaching Excellence Award in recognition of her outstanding contributions to student learning and mentorship.

Will be updated soon

Dr. Maryam Asadi Ph.D. in Molecular Medicine diploma from the American Board of Regenerative Medicine. Shiraz ACECR cell therapy department manager CEO and founder of Unihealthcity platform Shiraz ACECR polyclinic manager awarded the American Society of Regenerative Medicine Extraordinary Young Scientist award in 2024 the American Board of Regenerative Medicine as an affiliate in Iran.

Mr. Francis ("Frank") O'Keeffe is an Associate Lecturer at the University of Notre Dame Australia (Sydney). He is currently a PhD candidate nearing the end of his doctoral studies. His research investigates the ethical status of the human embryo. He is perhaps best known for an article titled, "Twinning and Individuation: An Appraisal of the Current Model and Ethical Implications." This work challenges the commonly held belief that identical twins may be formed by embryo splitting up to the fourteenth day of human embryogenesis. Mr O'Keeffe's research has also rejected the possibility that two separate human embryos could fuse into a single viable entity, which has prompted him to propose alternative models by which human chimeras may be formed. He is a critic of legislation which permits embryo experimentation during the first two weeks of human development. He has obtained a Master of Bioethics (MBioeth) and a Bachelor of Laws (LLB) from LaTrobe University (Melbourne).

Dr. Sowmithra is a Postdoctoral associate in Dr. Janghoo Lim lab in the Department of Genetics, Yale University School of Medicine in New Haven, United States. She holds a PhD in Biophysics from National Institute of Mental Health and Neurosciences, Bengaluru and master’s in biotechnology and molecular medicine from India. She studied the ‘Neuroprotective role of Mesenchymal stem cells on neural progenitors against hypoxic ischemic like injury’ under the guidance of Dr. Indrani Datta for her doctoral studies. In Lim lab she investigated the cellular phenotypes in human iPSCs derived neurons and astrocytes of spinocerebellar ataxia type 1.

Dr. Sumit Kumar Gupta is a distinguished academic leader and researcher with over 23 years of experience in higher education, research, and administration. He serves as Dean (Academic Affairs) at the University of Technology (NAAC B++ Grade). Holding dual Ph.D. degrees in Materials Science and Artificial Intelligence & Data Science, his expertise spans Physics, Nanotechnology, AI, Machine Learning, and Data Science. He holds 47 international patents, has published 45+ papers in reputed indexed journals, supervised multiple Ph.D. scholars, and authored seven textbooks. A NAAC Assessor and IIT-JEE Physics Subject Expert, he has received numerous honors, including the World Top Scientist Award (2024), Best Researcher Award, and Lifetime Achievement Award.

Dr. Latifa Gaddah is an Immunopathologist and Biotherapies Specialist with advanced expertise in immunogenetics, Biotherapies and high-reliability laboratory systems. With an academic and clinical background, including a Master’s degree in Genetics and specialization in Biotherapies and Doctorate in Medecine. She is international fellow of College of American Pathologists and a regional leader in implementing international standards across advanced diagnostics. She serves as a CAP Inspector Team Leader, AABB International Member and Assessor, and previously ISQua International Fellow, supporting institutions in achieving accreditation’s. Her work spans stem cell processing, cryopreservation, potency assessment, immunogenetics characterization, and cellular therapy quality management. She is Assistant Professor of Immunopathology, Immunogenetics Unit University of Medecine Sussa Tunisia. Dr. Gaddah is also the founder of YLM Training & Consultancy, delivering scientific education and capacity building across the MENA region. Her vision centers on integrating biotherapies, precision immunology, and advanced quality systems to elevate patient safety and deliver transformative clinical outcomes .

Mrs. Mina Shajarizadeh is a Ph.D. student in Molecular Medicine group department at Tehran University of Medical Sciences, Tehran, Iran. She obtained her Master’s degree in Medical Parasitology in 2018 and her Bachelor’s degree in Laboratory Sciences from Shahid Beheshti University of Medical Sciences, Tehran. She possesses over eleven years of professional experience in laboratories and research, including Cellular and Molecular biology,Biochemistry and Microbiology departments , and Management of Quality Control (QC) Processes in Clinical laboratories. Her research interests focus on stem cell biology and the expression of key genes in cellular differentiation, with a strong emphasis on regenerative medicine and cell therapy. She has collaborated on numerous scientific projects, such as investigating Ascl1 expression in human bone marrow mesenchymal stem cells and their differentiation into pancreatic beta cells, and examining the effects of exosomes secreted by hepatocytes under hyperglycemic conditions on insulin receptors in pancreatic cancer cell lines.

Mr. Calvin Jefferson is a Doctor of Health Science (DHSc) candidate at Touro University Worldwide and a published author, fine artist, and healthcare professional with over 15 years of experience. His work explores the intersection of socioeconomic equity and public trust in emerging biomedical technologies. Mr. Jefferson’s recent research focuses on regenerative medicine and ethical disparities in patient access and perception. He is also a Service-Disabled Veteran and founder of CE Jefferson Properties LLC.

Mrs. Juliana Leal Rodrigues da Costa is a Brazilian pharmacist, graduated from the Federal University of Juiz de Fora (UFJF), and currently a Master’s student in Pharmaceutical Sciences. She completed an academic exchange at Universität Rostock, Germany, where she was involved in research activities related to stem cell biology. Her current research focuses on the investigation of bioactive compounds and their effects on stem cells and cancer-related cellular models, aiming to better understand cellular responses, mechanisms of action, and potential therapeutic applications in oncology.

Dr. Mohammadali Zolfaghari is a PhD in Molecular Medicine and a Diplomate & Alpha Affiliated member of the American Board of Regenerative Medicine (ABRM). He serves as the Research and Development Manager at the Molecular Immunology Research Center, Tehran University of Medical Sciences, and represents Celltech Pharmed Company as its exclusive sales representative. His expertise lies in regenerative medicine, immunotherapy, and precision medicine, with a focus on translating laboratory discoveries into clinical applications. He is dedicated to developing innovative, patient-centered therapeutic strategies and fostering collaborations that advance healthcare through cutting-edge biomedical research.

Dr. Amrita Natarajan is a biomedical researcher with a multidisciplinary background in dentistry, nanomedical sciences, and bioengineering. She holds a B.D.S. from the Army College of Dental Sciences, an M.Tech in Nanomedical Sciences from AIMS, and a Ph.D. in Bioengineering with a focus on Tissue Engineering and Regenerative Medicine from SCTIMST, India. She has received prestigious fellowships from ICMR and CSIR, and has worked on DST-SERB-funded research. Her expertise lies in the development of advanced biomaterials, 3D bioprinted constructs, and in vitro disease models for regenerative therapies targeting cartilage, bone, and kidney tissues. Her work includes biomimetic scaffolds for cartilage repair, patterned hydrogels for renal tissue modeling, electrospun tubule models, and 3D-printed lattice scaffolds for various tissue regeneration applications. Dr. Natarajan previously served as Project Scientist C at ICMR, where she contributed to national biomedical ethics policy, including India’s 2023 CHIS policy statement. Currently, she is a National Science Foundation–funded Postdoctoral Research Scientist at Alabama State University, focusing on AI-driven renal tissue engineering. She also serves on doctoral advisory committees at multiple institutions. Her long-term vision integrates bioinspired design with advanced fabrication technologies for tissue repair and organ function restoration.